APPLICATION
BLA761268
TYPE
BLA
ORIGINAL APPROVAL
2022-09-27
LATEST ACTION
2022-09-27
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
VEGZELMAPrescription
BEVACIZUMAB-ADCD 400MG/16ML(25MG/ML) · INJECTABLE · INJECTION
VEGZELMAPrescription
BEVACIZUMAB-ADCD 100MG/4ML(25MG/ML) · INJECTABLE · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.